Heparinassoziiertes Thrombozyten-Aggregationssyndrom mit Hautnekrosen bei Hämodialyse

Ro, Bredlich; Stracke, Siegbert; Gall, Henning; Tm, Proebstle

doi:10.1055/s-2008-1047617

Cited by 9 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Compared to unfractionated heparin (UFH), low-molecular-weight heparins (LMWH) have a number of benefits and are becoming more and more essential in the prevention and treatment of thromboembolic illnesses. Among these include a more consistent pharmacokinetic profile, which results in increased antithrombotic efficacy at a decreased risk of bleeding, as well as a decreased risk of osteoporosis and heparin-induced thrombocytopenia with prolonged therapy 1 .Skin darkening is an extremely uncommon side effect of UFH treatment, while it has also been noted in a tiny percentage of instances following LMWH treatment [2][3][4] . We describe a patient whose LMWH caused skin darkening that was exacerbated by heparin.…”

Section: Introductionmentioning

confidence: 99%

"Unveiling the Enigma: A Rare Case of Low Molecular Weight Heparin-Induced Skin Discoloration"

Kumar,

Mishra,

Kumar

et al. 2024

IJERMDC

View full text Add to dashboard Cite

Skin discoloration, also known as skin decolorization, is an uncommon side effect that can occur after low molecular weight heparin (LMWH) is administered. We describe the case of a 33-year-old woman who complained of searing pains in both feet, feverish spells, and other symptoms when she visited the emergency room. She did, however, experience increased symptoms after receiving LMWH, such as abrasions and skin discolouration on her upper and lower limbs. This case emphasizes how crucial it is to take unusual drug reactions into account when treating patients who exhibit dermatological symptoms.

show abstract

Section: Introductionmentioning

confidence: 99%